y 27632 has been researched along with Cranial Nerve II Injuries in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Deng, L; Jiao, Q; Shen, X; Tan, H; Zhong, Y | 1 |
| Bähr, M; Lingor, P; Mack, H; Mueller, BK; Mueller, R; Schwarz, K; Teusch, N | 1 |
| Ichikawa, M; Sagawa, H; Saito, K; Tokita, Y; Watanabe, M; Yoshida, J | 1 |
3 other study(ies) available for y 27632 and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Erythropoietin promotes axonal regeneration after optic nerve crush in vivo by inhibition of RhoA/ROCK signaling pathway.
Topics: Amides; Animals; Axons; Blotting, Western; Cell Survival; Enzyme Inhibitors; Erythropoietin; GAP-43 Protein; Immunohistochemistry; Male; Nerve Crush; Nerve Regeneration; Optic Nerve; Optic Nerve Injuries; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Superior Colliculi | 2012 |
Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Axons; Cell Line; Chondroitin Sulfate Proteoglycans; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Intracellular Signaling Peptides and Proteins; Nerve Crush; Nerve Regeneration; Neurites; Neurons; Optic Nerve; Optic Nerve Injuries; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases | 2007 |
Differential effects of two ROCK inhibitors, Fasudil and Y-27632, on optic nerve regeneration in adult cats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Axons; Cats; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Male; Nerve Crush; Nerve Regeneration; Optic Nerve; Optic Nerve Injuries; Organ Culture Techniques; Protein Kinase Inhibitors; Pyridines; Retina; rho-Associated Kinases; Treatment Outcome; Wallerian Degeneration | 2008 |